Risk warning: Our products are leveraged and carry a high level of risk, which can result in the loss of your entire capital. Such products may not be suitable for all investors. It is crucial to understand the risks involved fully.
  • Support
  • For Institutionals
Risk warning: Our products are leveraged and carry a high level of risk, which can result in the loss of your entire capital. Such products may not be suitable for all investors. It is crucial to understand the risks involved fully.
  • Support
  • For Institutionals

Current region:

  • English
    ACTIVE
Other languages:
  • Español – Spanish
  • Português – Portuguese
  • English – International
  • 日本語 – Japanese
Risk warning: Our products are leveraged and carry a high level of risk, which can result in the loss of your entire capital. Such products may not be suitable for all investors. It is crucial to understand the risks involved fully.
Risk Warning: Leveraged products carry a high level of risk and may result in the loss of all your capital. Ensure you fully understand the risks before investing.
Risk Warning: Leveraged products carry a high level of risk and may result in the loss of all your capital. Ensure you fully understand the risks before investing.

Current region:

  • English
    ACTIVE
Other languages:
  • Español – Spanish
  • Português – Portuguese
  • English – International
  • 日本語 – Japanese
Risk Warning: Leveraged products carry a high level of risk and may result in the loss of all your capital. Ensure you fully understand the risks before investing.
Featured-DailyTechnical-EN

S&P 500 and Japan’s Hidden Market Influence

Yesterday we discussed the movements in the JPY, and as anticipated, today we will briefly cover their relevance for global

Featured-DailyTechnical-EN

S&P 500 Following Weak NFP and Retail Sales Data

As of yesterday’s close, the S&P 500 is up 15.62% year to date. This performance is broadly consistent with the

Featured-DailyTechnical-EN

Eli Lilly Holds Firm in the USD 1 Trillion Club

On Friday, 21 November 2025, Eli Lilly became the first pharmaceutical company to reach a valuation typically reserved for major

U.S. Stocks Trade Mixed: Nvidia Earnings, PMI Data, and Fed in the Spotlight

U.S. stock futures traded mixed on Monday as investors anticipated key earnings from chipmaker Nvidia (NVDA) and comments from several

Understanding the S&P 500: A Key Market Indicator

The S&P 500, also known as Standard and Poor’s 500, is one of the most recognized stock indexes globally and